Immuron (IMRN) Research & Development (2016 - 2024)
Immuron has reported Research & Development over the past 9 years, most recently at -$1296.2 billion for Q4 2024.
- For Q4 2024, Research & Development fell 7505098700.29% year-over-year to -$1296.2 billion; the TTM value through Dec 2024 reached -$1296.2 billion, down 93021450.4%, while the annual FY2025 figure was $2.3 million, 33.87% down from the prior year.
- Research & Development for Q4 2024 was -$1296.2 billion at Immuron, down from -$17271.3 in the prior quarter.
- Over five years, Research & Development peaked at $148106.7 in Q2 2023 and troughed at -$1296.2 billion in Q4 2024.
- A 5-year average of -$216.0 billion and a median of -$13088.5 in 2020 define the central range for Research & Development.
- Biggest five-year swings in Research & Development: surged 98.86% in 2023 and later plummeted 7505098700.29% in 2024.
- Year by year, Research & Development stood at -$8905.8 in 2020, then surged by 69.96% to -$2675.6 in 2021, then crashed by 56770.31% to -$1.5 million in 2022, then surged by 98.86% to -$17271.3 in 2023, then plummeted by 7505098700.29% to -$1296.2 billion in 2024.
- Business Quant data shows Research & Development for IMRN at -$1296.2 billion in Q4 2024, -$17271.3 in Q4 2023, and $148106.7 in Q2 2023.